6
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Tumour Necrosis Factor Synergises with Gamma Interferon on the Induction of mRNA for DR Alpha Chain on Thyrocytes from Graves' Disease and Non Toxic Goitre

, , , &
Pages 255-266 | Received 30 Apr 1989, Published online: 07 Jul 2009
 

Abstract

In both thyroid autoimmune diseases Graves' and Hashimoto's thyroiditis, the epithelial thyroid follicular cells (TFC) have been shown to express HLA class II molecules, and can restimulate autoreactive T cells cloned from the diseased tissue. This aberrant class II expression is important in the mechanism of perpetuation of the disease process, therefore we have compared the effect of interferon γ (IFNγ) and tumour necrosis factor (TNFα) on the HLA-DRα mRNA expression of thyroid follicular cells derived from Graves' disease (GD) and a non autoimmune disease, non toxic goitre (NTG).

Our results indicate that TNFα synergises with IFNγ in the induction of HLA class II mRNA. There was no consistent difference in DRα mRNA expression between the GD and NTG thyroid follicular cell preparations in response to induction by a combination of these lymphokines at various concentrations. Our data suggest that the differences in the level of expression of class II molecules observed in vivo in Graves' disease and non toxic goitre, which is much higher in the former, is probably due to local release of lymphokines by infiltrating T lymphocytes, although other factors may be involved.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.